FOXO3 and cancer: We have exemplified “protein interference” using the FOXO3a signaling pathway, a tumor-suppressive network that is frequently inactivated in human cancers by post-translational modifications rather than genetic mutations (Dansen and Burgering, 2008; Yang and Hung, 2009; Zanella and Carnero, 2009).